Results 11 to 20 of about 182,065 (262)

Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial Hypercholesterolemia [PDF]

open access: green, 1984
A six-year-old girl with severe hypercholesterolemia and atherosclerosis had two defective genes at the low-density-lipoprotein (LDL) receptor locus, as determined by biochemical studies of cultured fibroblasts.
David W. Bilheimer   +4 more
openalex   +3 more sources

Systematic review and network meta-analysis on the efficacy of evolocumab and other therapies for the management of lipid levels in hyperlipidemia [PDF]

open access: yes, 2017
Background: The proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors evolocumab and alirocumab substantially reduce low‐density lipoprotein cholesterol (LDL‐C) when added to statin therapy in patients who need additional LDL‐C reduction ...
Bray, Sarah   +13 more
core   +1 more source

New approaches in detection and treatment of familial hypercholesterolemia [PDF]

open access: yes, 2015
Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder that clinically leads to increased low density lipoprotein-cholesterol (LDL-C) levels. As a consequence, FH patients are at high risk for cardiovascular disease (CVD). Mutations
Hartgers, ML, Hovingh, GK, Ray, KK
core   +3 more sources

Metabolism of low-density lipoproteins by cultured hepatocytes from normal and homozygous familial hypercholesterolemic subjects [PDF]

open access: yes, 1986
The profoundly elevated concentrations of low-density lipoproteins (LDL) present in homozygous familial hypercholesterolemia lead to symptomatic cardiovascular disease and death by early adulthood.
Brewer, HB   +6 more
core   +1 more source

Prevention of High-Fat Diet-Induced Hypercholesterolemia by Lactobacillus reuteri Fn041 Through Promoting Cholesterol and Bile Salt Excretion and Intestinal Mucosal Barrier Functions

open access: yesFrontiers in Nutrition, 2022
Objectives:Lactobacillus reuteri Fn041 (Fn041) is a probiotic isolated from immunoglobulin A coated microbiota in the human breast milk of Gannan in China with a low incidence of hypercholesterolemia.
Mengyao Lu   +10 more
doaj   +1 more source

Mediterranean diet adherence and synergy with acute myocardial infarction and its determinants. a multicenter case-control study in Italy. [PDF]

open access: yes, 2018
Cardiovascular diseases are the leading causes of mortality and morbidity in Western countries. The possible synergistic effect of poor adherence to a Mediterranean diet (MD) and other risk factors for acute myocardial infarction (AMI) such as ...
Agati, L   +10 more
core   +1 more source

Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issues

open access: yesAmerican Journal of Preventive Cardiology, 2021
Objective: To assess adherence to lipid lowering therapy (LLT), reasons for poor adherence, and achievement of LDL-C treatment goals in children and young adults with familial hypercholesterolemia (FH).
Gisle Langslet   +6 more
doaj  

Socioeconomic inequalities of hypercholesterolemia in Kurdistan Province, Iran, in 2005

open access: yesChronic Diseases Journal, 2015
BACKGROUND: Hypercholesterolemia is one of the main risk factors for many non-communicable diseases (NCDs). Many deaths caused by hypercholesterolemia usually occur in low and middle income countries.
Fatemeh Gholami, Ghobad Moradi
doaj   +1 more source

Familywise error control in multi-armed response-adaptive trials [PDF]

open access: yesBiometrics 2019, 75(3):885-894, 2018
Response-adaptive designs allow the randomization probabilities to change during the course of a trial based on cumulated response data, so that a greater proportion of patients can be allocated to the better performing treatments. A major concern over the use of response-adaptive designs in practice, particularly from a regulatory viewpoint, is ...
arxiv   +1 more source

Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia

open access: yesMedicine Science, 2022
Familial hypercholesterolemia is a metabolic disease caused by a mutation in the low-density lipoprotein receptor gene. It carries early atherosclerosis and coronary artery disease risks.
Mehmet Oncul   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy